An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses. (Q48908840)

16 February 2018

title

An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses. (English)

1 reference

16 February 2018

1 reference

Marta Serati

2

0 references

Bernardo Dell'Osso

object named as

Bernardo Dell'Osso

6

0 references

author name string

A Carlo Altamura

1

1 reference

16 February 2018

Alessandra Albano

3

1 reference

16 February 2018

Riccardo A Paoli

4

1 reference

16 February 2018

Ira D Glick

5

1 reference

16 February 2018

publication date

18 February 2011

1 reference

16 February 2018

European Archives of Psychiatry and Clinical Neuroscience

published in

1 reference

16 February 2018

volume

261

1 reference

16 February 2018

issue

7

1 reference

16 February 2018

page(s)

489-508

1 reference

16 February 2018

https://scigraph.springernature.com/pub.10.1007/s00406-011-0196-4

exact match

0 references

cites work

Phenotype of schizophrenia: a review and formulation

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

The concept of psychosis: historical and phenomenological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Psychosis: a history of the concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

The concept of Schizophrenia. Kraepelin-Bleuler-Schneider.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Assessment of insight in psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

The Kraepelinian dichotomy: the twin pillars crumbling?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Diagnosis and course of affective psychoses: was Kraepelin right?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

From Kraepelin to Kretschmer leavened by Schneider: thextransition from categories of psychosis to dimensions of variation intrinsic to homo sapiens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Genetics of affective (mood) disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Are some genetic risk factors common to schizophrenia, bipolar disorder and depression? Evidence from DISC1, GRIK4 and NRG1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Epigenetic and pharmacoepigenomic studies of major psychoses and potentials for therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Psychiatric genetics: progress amid controversy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Imbalanced genomic imprinting in brain development: an evolutionary basis for the aetiology of autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Evolution in health and medicine Sackler colloquium: Comparative genomics of autism and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Bipolar disorder, schizoaffective disorder, and schizophrenia overlap: a new comorbidity index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Disruption of cortical-limbic interaction as a substrate for comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Meta-analytic evidence for familial coaggregation of schizophrenia and bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Evidence for shared susceptibility in bipolar disorder and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Rare copy number variants: a point of rarity in genetic risk for bipolar disorder and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Psychiatric and medical comorbidities of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Clinical utility: a prerequisite for the adoption of a dimensional approach in DSM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Schizophrenia: a concise overview of incidence, prevalence, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Medical comorbidity in women and men with schizophrenia: a population-based controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Medical comorbidity in psychiatric inpatients: relation to clinical outcomes and hospital length of stay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

A Systematic Review of Mortality in Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Psychiatric disorders, HIV infection and HIV/hepatitis co-infection in the correctional setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Oral health of psychiatric in-patients in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Schizophrenia and sudden cardiac death: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Somatic hospital contacts, invasive cardiac procedures, and mortality from heart disease in patients with severe mental disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

The thyroid-brain interaction in thyroid disorders and mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Management of schizophrenia with obesity, metabolic, and endocrinological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

The metabolic syndrome and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Clustering of schizophrenia with other comorbidities--what can we learn?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Physical illness and schizophrenia: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Causes of the excess mortality of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Risk of stillbirth and neonatal death linked with maternal mental illness: a national cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Comparing the safety and efficacy of atypical antipsychotics in psychiatric patients with comorbid medical illnesses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Somatic diseases in patients with schizophrenia in general practice: their prevalence and health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

The impact of mental illness on cardiac outcomes: a review for the cardiologist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

The current status of tardive dyskinesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Differential diagnoses and management strategies in patients with schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Psychiatric comorbidities and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Substance use disorders in schizophrenia--clinical implications of comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Prevalence of psychosis/substance abuse comorbidity. Clinical-epidemiological findings from different treatment settings in a large German city

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Neuroimaging communality between schizophrenia and obsessive compulsive disorder: a putative basis for schizo-obsessive disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Early prodromal symptoms and diagnoses before first psychotic episode in 219 inpatients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Depression in schizophrenia: perspective in the era of "Atypical" antipsychotic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Depression in the long-term course of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Prevalence and relationship to delusions and hallucinations of anxiety disorders in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Co-morbid social phobia in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Gene-environment interplay between cannabis and psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

A neurobiological basis for substance abuse comorbidity in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

The prediction of criminal and violent recidivism among mentally disordered offenders: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Depressive symptoms in schizophrenia: comprehensive differential diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Subjective quality of life in first episode schizophrenia spectrum disorders with comorbid depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Occurrence and treatment of depressive comorbidity/cosyndromality in schizophrenic psychoses: conceptual and treatment issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Clinical evaluation of negative symptoms in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Fourteen-year prospective follow-up study of positive and negative symptoms in chronic schizophrenic patients dying from suicide compared to other causes of death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Suicide and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

The 'atypicality' of antipsychotics: a concept re-examined and re-defined

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Arterial stiffness and stroke in hypertension: therapeutic implications for stroke prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Tobacco smoking behaviors in bipolar disorder: a comparison of the general population, schizophrenia, and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Treatment of schizophrenia and comorbid substance use disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Role for dopamine in the behavioral functions of the prefrontal corticostriatal system: implications for mental disorders and psychotropic drug action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Cannabis and the course of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Pharmacotherapy of schizophrenia with comorbid substance use disorder--reviewing the evidence and clinical recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Clinical complexity and person-centered integrative diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Intramuscular preparations of antipsychotics: uses and relevance in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Factors affecting outcome in schizophrenia and their relevance for psychopharmacological treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Drawing up guidelines for the attendance of physical health of patients with severe mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Health care utilization and costs among privately insured patients with bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Health and economic burden of metabolic comorbidity among individuals with bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Medical comorbidity and health-related quality of life in bipolar disorder across the adult age span.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Medical comorbidity in women and men with bipolar disorders: a population-based controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Gender differences in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Medical and substance use comorbidity in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Medical comorbidity in bipolar disorder: re-prioritizing unmet needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

The prevalence and impact of migraine headache in bipolar disorder: results from the Canadian Community Health Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Obesity as a correlate of outcome in patients with bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Bipolar disorder and the metabolic syndrome: causal factors, psychiatric outcomes and economic burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Increased risk of developing dementia in patients with major affective disorders compared to patients with other medical illnesses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Enhanced cancer risk among patients with bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

The effects of undertreated chronic medical illnesses in patients with severe mental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

The phenomenology of bipolar disorder: what drives the high rate of medical burden and determines long-term prognosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Understanding needs, interactions, treatment, and expectations among individuals affected by bipolar disorder or schizophrenia: the UNITE global survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Comorbidity in mania at first hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

The effect of comorbid substance use disorders on the course of bipolar disorder: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

The epidemiology of DSM-III-R bipolar I disorder in a general population survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Anxiety disorders and risk for suicidal ideation and suicide attempts: a population-based longitudinal study of adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Relationships among psychosocial functioning, diagnostic comorbidity, and the recurrence of generalized anxiety disorder, panic disorder, and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Bipolar-panic disorder comorbidity within bipolar disorder families: a study of siblings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Panic comorbidity with bipolar disorder: what is the manic-panic connection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Anxiety disorders and suicidal behaviour: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

A review of panic and suicide in bipolar disorder: does comorbidity increase risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Duration of untreated illness and suicide in bipolar disorder: a naturalistic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Risk of suicide attempt and suicide death in patients treated for bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Impact of childhood abuse on the course of bipolar disorder: a replication study in U.S. veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Posttraumatic stress disorder in patients with bipolar disorder: a review of prevalence, correlates, and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Gender differences in bipolar disorder: retrospective data from the first 500 STEP-BD participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Comorbid anxiety in bipolar disorder alters treatment and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Prevalence and risk factors associated with suicide ideation and attempts in korean college students

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Suicide risk in bipolar patients: the role of co-morbid substance use disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Differential interactions between comorbid anxiety disorders and substance use disorder in rapid cycling bipolar I or II disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Comorbidity of eating disorders with bipolar disorder and treatment implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

The prevalence and co-morbidity of subthreshold psychiatric conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Pharmacological treatment of psychiatric comorbidity in bipolar disorder: a review of controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Antidepressants in bipolar disorder: the case for caution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Clinical variables related to antidepressant-induced mania in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Antidepressant-induced mania and cycle acceleration: a controversy revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Diagnosis and treatment of obsessive-compulsive disorder and related disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Treatment of social phobia with gabapentin: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Oral topiramate for treatment of alcohol dependence: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Aripiprazole: profile on efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Effects on weight and outcome of long-term olanzapine-topiramate combination treatment in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Psychotic depression and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Depression status, medical comorbidity and resource costs. Evidence from an international study of major depression in primary care (LIDO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

HPA-axis hyperactivity and mortality in psychotic depressive disorder: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Prevalence and clinical characteristics of psychotic versus nonpsychotic major depression in a general psychiatric outpatient clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

The validity of major depression with psychotic features based on a community study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Importance of psychotic features to long-term course in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Neuropsychological correlates of psychotic features in major depressive disorders: a review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Severe depression: is there a best approach?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Glucocorticoid inhibition in the treatment of depression: can we think outside the endocrine hypothalamus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

The 'continuum of psychosis': scientifically unproven and clinically impractical.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Phenomenology and Prognostic Significance of Delusions in Major Depressive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Increased Mortality Among Patients Admitted With Major Psychiatric Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Lifetime co-morbidities between social phobia and mood disorders in the US National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Panic disorder with familial bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Effect of comorbid anxiety on treatment response in bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

Prevalence of obesity and weight change during treatment in patients with bipolar I disorder

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00406-011-0196-4

21 January 2018

12 December 2020

Phenomenology and prognostic significance of delusions in major depressive disorder: a 10-year prospective follow-up study

1 reference

12 December 2020

Neurocognitive deterioration in elderly chronic schizophrenia patients with and without PTSD.

1 reference

12 December 2020

The increasing medical burden in bipolar disorder

1 reference

12 December 2020

Treatment of bulimia and rapid-cycling bipolar disorder with sodium valproate: a case report

1 reference

12 December 2020

Relationships between obsessive-compulsive symptomatology and severity of psychosis in schizophrenia: a systematic review and meta-analysis.

1 reference

12 December 2020

Medical comorbidity in a bipolar outpatient clinical population

1 reference

12 December 2020

Novel antipsychotics and the problem of clinical stabilization in schizophrenia: are they "stabilizer" rather than typical compounds?

1 reference

12 December 2020

The emerging epidemiology of hypomania and bipolar II disorder

1 reference

12 December 2020

Clinical and demographic features of psychotic and nonpsychotic depression

1 reference

12 December 2020

The prevalence of migraine in patients with bipolar and unipolar affective disorders

1 reference

12 December 2020

The prevalence and clinical correlates of metabolic syndrome in patients with schizophrenia: findings from a cohort in Turkey.

1 reference

12 December 2020

Delusional and nondelusional unipolar depression: further evidence for distinct subtypes

1 reference

12 December 2020

Impact of comorbid anxiety disorders on outcome in a cohort of patients with bipolar disorder

1 reference

12 December 2020

The clinical and neuroendocrine features of psychotic depression.

1 reference

12 December 2020

Hospital-based psychiatric service utilization and morbidity in multiple sclerosis

1 reference

12 December 2020

Chronology of comorbid and principal syndromes in first-episode psychosis

1 reference

12 December 2020

Symptomatologic analysis of psychotic and non-psychotic depression

1 reference

12 December 2020

Bipolar disorder and panic disorder in families: an analysis of chromosome 18 data.

1 reference

12 December 2020

Psychotic subtyping of major depressive disorder and posttraumatic stress disorder

1 reference

12 December 2020

Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study.

1 reference

12 December 2020

Post-Traumatic Stress Disorder in subjects with schizophrenia and bipolar disorder.

1 reference

12 December 2020

Patterns of Axis I comorbidity in relation to age in patients with Bipolar Disorder: a cross-sectional analysis.

1 reference

12 December 2020

Nosologomania: DSM & Karl Jaspers' critique of Kraepelin

1 reference

12 December 2020

Occurrence and clinical correlates of psychiatric comorbidity in patients with psychotic disorders.

1 reference

12 December 2020

Comorbidity in bipolar disorder: clinical and research opportunities

1 reference

12 December 2020

Prevalence of axis II comorbidity in bipolar patients with and without alcohol use disorders

1 reference

12 December 2020

Persistent posttraumatic stress disorder following September 11 in patients with bipolar disorder.

1 reference

12 December 2020

Patients with multiple sclerosis presenting to psychiatric hospitals.

1 reference

12 December 2020

Parallel fluctuations of psychiatric and neurological symptoms in a patient with multiple sclerosis and bipolar affective disorder

1 reference

12 December 2020

Medical risk in patients with bipolar disorder and schizophrenia.

1 reference

12 December 2020

Correlates of overweight and obesity in 644 patients with bipolar disorder

1 reference

12 December 2020

The epidemiology of social anxiety disorder in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions

1 reference

12 December 2020

Clinical depression in alcoholism

1 reference

12 December 2020

Does comorbid posttraumatic stress disorder affect the severity and course of psychotic major depressive disorder?

1 reference

12 December 2020

Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study.

1 reference

12 December 2020

Psychiatric and general medical conditions comorbid with schizophrenia in the National Hospital Discharge Survey

1 reference

12 December 2020

Aripiprazole in schizophrenia patients with comorbid obsessive-compulsive symptoms: an open-label study of 15 patients

1 reference

12 December 2020

Relationship of general medical burden, duration of illness and age in patients with bipolar I disorder

1 reference

12 December 2020

Antipsychotic medications: metabolic and cardiovascular risk

1 reference

12 December 2020

Mortality of patients with mood disorders: follow-up over 34-38 years

1 reference

12 December 2020

Premature mortality from general medical illnesses among persons with bipolar disorder: a review

1 reference

12 December 2020

Multiple anxiety disorder comorbidity in patients with mood spectrum disorders with psychotic features

1 reference

12 December 2020

Psychotropic drugs induced weight gain: a review of the literature concerning epidemiological data, mechanisms and management

1 reference

12 December 2020

Psychiatric comorbidity in older adults with bipolar disorder

1 reference

12 December 2020

How and why genetic linkage has not solved the problem of psychosis: review and hypothesis

1 reference

12 December 2020

Predictors for switch from unipolar major depressive disorder to bipolar disorder type I or II: a 5-year prospective study.

1 reference

12 December 2020

Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists

1 reference

12 December 2020

Influence of comorbid alcohol and psychiatric disorders on utilization of mental health services in the National Comorbidity Survey.

1 reference

12 December 2020

Psychotic disorders and comorbidity: somatic illness vs. side effect.

1 reference

12 December 2020

The economic impact of bipolar disorder in an employed population from an employer perspective.

1 reference

12 December 2020

Association between bipolar affective disorder and multiple sclerosis

1 reference

12 December 2020

Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review

1 reference

12 December 2020

Akinesia and postpsychotic depression: a difficult differential diagnosis

1 reference

12 December 2020

Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches

1 reference

12 December 2020

Schizophrenia and violence: systematic review and meta-analysis

1 reference

12 December 2020

Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia.

1 reference

12 December 2020

Course of psychiatric and substance abuse syndromes co-occurring with bipolar disorder after a first psychiatric hospitalization.

1 reference

12 December 2020

[Antipsychotics and hyperpolactinaemia: pathophysiology, clinical relevance, diagnosis and therapy].

1 reference

12 December 2020

Is delusional depression related to bipolar disorder?

1 reference

12 December 2020

Adjunctive valproate in panic disorder patients with comorbid bipolar disorder or otherwise resistant to standard antidepressants: a 3-year "open" follow-up study

1 reference

12 December 2020

Comorbidity of panic disorder in bipolar illness: evidence from the Epidemiologic Catchment Area Survey

1 reference

12 December 2020

Two-stage case-control association study of polymorphisms in rheumatoid arthritis susceptibility genes with schizophrenia

1 reference

12 December 2020

Depression, demoralization and control over psychotic illness: a comparison of depressed and non-depressed patients with a chronic psychosis.

1 reference

12 December 2020

Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: a 4-year follow-up naturalistic study.

1 reference

12 December 2020

Common polygenic variation contributes to risk of schizophrenia and bipolar disorder

1 reference

12 December 2020

Comorbidity of fibromyalgia and psychiatric disorders

1 reference

12 December 2020

Size and burden of mental disorders in Europe—a critical review and appraisal of 27 studies

1 reference

12 December 2020

Lamotrigine augmentation in schizophrenia and schizoaffective patients with obsessive-compulsive symptoms

1 reference

12 December 2020

Do atypical antipsychotics effectively treat co-occurring bipolar disorder and stimulant dependence? A randomized, double-blind trial

1 reference

12 December 2020

Bipolar disorder and comorbid personality psychopathology: a review of the literature

1 reference

12 December 2020

Bipolar I, bipolar II, and nonbipolar major depression among the relatives of affectively ill probands.

1 reference

12 December 2020

10.1007/S00406-011-0196-4

Identifiers

DOI

1 reference

16 February 2018

1 reference

16 February 2018